Clinical Trial Update: Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing intravitreal bevacizumab alone versus bevacizumab in combination with photodynamic therapy for exudative age-related mac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab) (bevacizumab)
• Visudyne (verteporfin) (verteporfin)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Macular Degeneration | Phase 2 | Status: UNKNOWN